These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 2531843
21. Alterations in the extracellular matrix components in human glomerular diseases. Oomura A, Nakamura T, Arakawa M, Ooshima A, Isemura M. Virchows Arch A Pathol Anat Histopathol; 1989; 415(2):151-9. PubMed ID: 2500770 [Abstract] [Full Text] [Related]
22. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome. Vernier RL, Klein DJ, Sisson SP, Mahan JD, Oegema TR, Brown DM. N Engl J Med; 1983 Oct 27; 309(17):1001-9. PubMed ID: 6225948 [Abstract] [Full Text] [Related]
23. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM. Kidney Int; 1992 Apr 27; 41(4):1070-80. PubMed ID: 1513088 [Abstract] [Full Text] [Related]
24. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Tamsma JT, van den Born J, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH. Diabetologia; 1994 Mar 27; 37(3):313-20. PubMed ID: 8174847 [Abstract] [Full Text] [Related]
25. [Changes in anionic sites on glomerular basement membrane following mesangiolysis--observation in incipient anti-rat Thy1 nephritis]. Ohe K. Nihon Jinzo Gakkai Shi; 1993 Sep 27; 35(9):1007-14. PubMed ID: 8230810 [Abstract] [Full Text] [Related]
26. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. van Bruggen MC, Kramers K, Hylkema MN, van den Born J, Bakker MA, Assmann KJ, Smeenk RJ, Berden JH. Am J Pathol; 1995 Mar 27; 146(3):753-63. PubMed ID: 7534044 [Abstract] [Full Text] [Related]
27. Glomerular basement membrane proteoglycans are derived from a large precursor. Klein DJ, Brown DM, Oegema TR, Brenchley PE, Anderson JC, Dickinson MA, Horigan EA, Hassell JR. J Cell Biol; 1988 Mar 27; 106(3):963-70. PubMed ID: 2964453 [Abstract] [Full Text] [Related]
28. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage. Wijnhoven TJ, Lensen JF, Wismans RG, Lefeber DJ, Rops AL, van der Vlag J, Berden JH, van den Heuvel LP, van Kuppevelt TH. J Am Soc Nephrol; 2007 Dec 27; 18(12):3119-27. PubMed ID: 18003778 [Abstract] [Full Text] [Related]
29. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin. Klein DJ, Dehnel PJ, Oegema TR, Brown DM. Lab Invest; 1984 May 27; 50(5):543-51. PubMed ID: 6232422 [Abstract] [Full Text] [Related]
30. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Raats CJ, Van Den Born J, Berden JH. Kidney Int; 2000 Feb 27; 57(2):385-400. PubMed ID: 10652015 [Abstract] [Full Text] [Related]
31. Distribution of the extracellular matrix components in human glomerular lesions. Büyükbabani N, Droz D. J Pathol; 1994 Feb 27; 172(2):199-207. PubMed ID: 8169750 [Abstract] [Full Text] [Related]
32. Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis? Berden JH, Termaat RM, Brinkman K, Smeenk RJ, Swaak AJ, Faaber P, Assmann K, van de Heuvel LP, Veerkamp JH. Nephrologie; 1989 Feb 27; 10(3):127-32. PubMed ID: 2532712 [Abstract] [Full Text] [Related]
33. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. J Histochem Cytochem; 1994 Jan 27; 42(1):89-102. PubMed ID: 8263327 [Abstract] [Full Text] [Related]
34. Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats. Heeringa P, Van den Born J, Brouwer E, Dolman KM, Klok PA, Huitema MG, Limburg PC, Bakker MA, Berden JH, Daha MR, Kallenberg CG. Clin Exp Immunol; 1996 Aug 27; 105(2):321-9. PubMed ID: 8706341 [Abstract] [Full Text] [Related]
35. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues]. Nerlich A. Veroff Pathol; 1995 Aug 27; 145():1-139. PubMed ID: 8638427 [Abstract] [Full Text] [Related]
36. Isolation and immunochemical characterization of heparan sulfate rich proteoglycan (HSPG) present in the basement membrane of human placenta. Onodera S, Sasaki T, Tashiro S. Biol Pharm Bull; 1997 Feb 27; 20(2):113-7. PubMed ID: 9057969 [Abstract] [Full Text] [Related]
37. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. Levidiotis V, Freeman C, Punler M, Martinello P, Creese B, Ferro V, van der Vlag J, Berden JH, Parish CR, Power DA. J Am Soc Nephrol; 2004 Nov 27; 15(11):2882-92. PubMed ID: 15504941 [Abstract] [Full Text] [Related]
38. Polycation binding to glomerular basement membrane. Effect of biochemical modification. Bertolatus JA, Hunsicker LG. Lab Invest; 1987 Feb 27; 56(2):170-9. PubMed ID: 3807316 [Abstract] [Full Text] [Related]
39. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate? van den Born J, Berden JH. Nephrol Dial Transplant; 1995 Feb 27; 10(8):1277-9. PubMed ID: 8538909 [No Abstract] [Full Text] [Related]
40. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis. Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y. J Lab Clin Med; 2004 Feb 27; 143(2):106-14. PubMed ID: 14966466 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]